IXICO plc provides technology enabled services to the biopharmaceutical industry worldwide. The company's technologies include Assessa, a secure online digital platform that provides clinical decision support for patient selection and post-marketing surveillance; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, QC, and reading/analysis to reporting and data transfer. The company offers end-to-end imaging services, primarily in the fields of Alzheimer's, Parkinson's, Huntington's, multiple sclerosis, cerebrovascular, and progressive supranuclear palsy diseases; and engages in the data collection and analysis of neurological diseases. Its services are used to select patients for clinical trials, assess the safety and efficacy of new drugs in development, and in post marketing surveillance. The company was incorporated in 1995 and is based in London, the United Kingdom.
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+44-20-37637499
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales£5.39 million
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date5/22/2019 (Estimated)
OptionableNot Optionable
Ixico (LON:IXI) Frequently Asked Questions
What is Ixico's stock symbol?
Ixico trades on the London Stock Exchange (LON) under the ticker symbol "IXI."
How were Ixico's earnings last quarter?
Ixico Plc (LON:IXI) issued its quarterly earnings data on Tuesday, December, 4th. The company reported ($2.00) EPS for the quarter, missing analysts' consensus estimates of ($1.50) by $0.50. View Ixico's Earnings History.
When is Ixico's next earnings date?
Has Ixico been receiving favorable news coverage?
Press coverage about IXI stock has trended very negative this week, InfoTrie reports. The research firm ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Ixico earned a media sentiment score of -3.6 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the next few days.
Who are some of Ixico's key competitors?
Some companies that are related to Ixico include Aerpio Pharmaceuticals (ARPO), Oncolytics Biotech (ONC), Zelda Therapeutics (ZLD), Novoheart (NVH), DiaMedica Therapeutics (DMA), Silence Therapeutics (SLN), Destiny Pharma (DEST), C4X Discovery (C4XD), Sirona Biochem (SBM), Acrux (ACR), Galena Biopharma (SLS), Ceapro (CZO), Altimmune (ALT), Rexahn Pharmaceuticals (RNN) and Rexahn Pharmaceuticals (RNN).
What other stocks do shareholders of Ixico own?
Who are Ixico's key executives?
Ixico's management team includes the folowing people:
- Mr. Giulio Cerroni, CEO & Director (Age 57)
- Prof. Derek Lionel Glendon Hill, Co-Founder and Pres of Regulatory Science & External Relations (Age 53)
- Prof. Daniel Rueckert, Co-Founder & Member of Scientific Advisory Board
- Prof. David Hawkes, Co-Founder & Member of Scientific Advisory Board
- Prof. Joseph Hajnal, Co-Founder & Member of Scientific Advisory Board
How do I buy shares of Ixico?
Shares of IXI and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Ixico's stock price today?
One share of IXI stock can currently be purchased for approximately GBX 27.50.
How big of a company is Ixico?
Ixico has a market capitalization of £12.86 million and generates £5.39 million in revenue each year.
What is Ixico's official website?
How can I contact Ixico?
Ixico's mailing address is 4th Fl, Griffin Court, 15 Long Lane, LONDON, EC1A 9PN, United Kingdom. The company can be reached via phone at +44-20-37637499.
MarketBeat Community Rating for Ixico (LON IXI)
MarketBeat's community ratings are surveys of what our community members think about Ixico and other stocks. Vote "Outperform" if you believe IXI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IXI will underperform the S&P 500 over the long term. You may vote once every thirty days.
